* To be consumed as directed by physician.

Ositab 80mg Tablet

(0.0 Rating)
Composition :

Osimertinib Tablets

Description :

Osimertinib is in a class of medications called kinase inhibitors, it is a third generation of kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells and may help shrink tumors.

Indication :

It is indicated for management of EGFR mutated NSCLC (Non small cell lung cancer) who have already progressed on or after taking EGFR TKI therapy

Share :

Dyronib 50mgTablets

(4.8 Rating)

Dyronib 50mgTablets

(4.8 Rating)
Composition :

Dasatinib 50mg

Description :

Newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase. Adults with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib. Adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL) with resistance or intolerance to prior therapy. Paediatric patients 1 year of age and older with Ph+ CML in chronic phase. Paediatric patients 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy.

Share :

Product Enquiry

Reach out for detailed information and personalized assistance.

0/600

Contact Us

To order or to know more details about Menthopas, reach us by filling the form. We will get back you within 1-2 business days.

Corporate Office

Hetero Healthcare Limited
Sy.No 80-84, Melange Towers,
4th Floor, C Wing, Patrika Nagar,
Madhapur, Hyderabad, Telangana
500081, India.

Marketing Offfice

Hetero Healthcare Limited
A-202/B201, Dipit Classic,
32/34, W.T.Suren Road,
Andheri(East), Mumbai, Maharashtra
400093, India.

Call us to talk

Send us a question

Follow Us

0/600